Department of Anesthesiology and Pain Medicine, Kosin University College of Medicine, Busan, Korea.
Korean J Anesthesiol. 2010 Feb;58(2):117-21. doi: 10.4097/kjae.2010.58.2.117. Epub 2010 Feb 28.
It is well known that opioids induce coughing. Many drugs such as lidocaine and ketamine are used to effectively prevent the coughing induced by opioids and this has been revealed to be effective. In this study, we evaluated the preventive effect of a graded escalation of the remifentanil concentration using a target controlled infusion pump and we compared this with the effect of lidocaine.
One hundred fifty ASA I and II patients who were scheduled for elective surgery were randomly divided into 3 groups. The patients were pretreated with 2% lidocaine 1 mg/kg (Group L) or saline (Group S) and remifentanil infusion (an effect site concentration of 4.0 ng/ml) was followed 1 minute later by using a target controlled infusion pump. Group R was pretreated with saline and this was followed by remifentanil infusion (effect site concentration of 2.0 ng/ml at first and then it was reset to 4.0 ng/ml). We evaluated the incidence, severity and onset time of cough after remifentanil infusion.
The incidence of coughing was significantly decreased in Group R (6 cases, 12%) and Group L (7 cases, 14%), as compared to that of Group S (17 cases, 34%) (P < 0.05), but there was no significant difference between Group R and Group L. The groups showed no significant difference in the severity and the onset time of coughing.
This study demonstrated that administering graded escalation of the remifentanil concentration suppresses remifentanil-induced coughing as effectively as lidocaine 1 mg/kg pretreatment.
众所周知,阿片类药物会引起咳嗽。许多药物,如利多卡因和氯胺酮,被用于有效地预防阿片类药物引起的咳嗽,这已被证明是有效的。在这项研究中,我们评估了使用靶控输注泵逐渐增加瑞芬太尼浓度的预防效果,并将其与利多卡因的效果进行了比较。
150 名 ASA I 和 II 级择期手术患者随机分为 3 组。患者预先给予 2%利多卡因 1mg/kg(L 组)或生理盐水(S 组),1 分钟后使用靶控输注泵给予瑞芬太尼输注(效应部位浓度为 4.0ng/ml)。R 组预先给予生理盐水,然后给予瑞芬太尼输注(首先为效应部位浓度 2.0ng/ml,然后重置为 4.0ng/ml)。我们评估了瑞芬太尼输注后咳嗽的发生率、严重程度和发作时间。
与 S 组(34%,17/50)相比,R 组(6 例,12%)和 L 组(7 例,14%)咳嗽发生率显著降低(P<0.05),但 R 组和 L 组之间无显著差异。各组咳嗽的严重程度和发作时间无显著差异。
本研究表明,给予瑞芬太尼浓度逐渐增加可有效抑制瑞芬太尼引起的咳嗽,与 1mg/kg 利多卡因预处理效果相当。